Inside Precision Medicine’s VP and publisher Bill Levine joins North American Editor Jonathan D. Grinstein, PhD, for a recap of how the molecular pathology community—from clinical labs and health systems to the biopharma industry—is reacting to the FDA’s ruling on laboratory-developed tests (LDTs), integrating advancements in digital pathology and precision medicine into clinical care, and more.
Produced by Bill Levine
Hosted by Jonathan D. Grinstein
Music provided by Oleksii Holubiev
Audio mixed and mastered by Jason Mack
Hosted on Acast. See acast.com/privacy for more information.
Nov 22 202419 min